No Data
No Data
Citi Upgrades Illumina, Quest, Agilent to Buy, Downgrades Avantor
Oppenheimer's Top SMID Ideas Within High-growth Themes
Drug Middlemen Pay Higher Prices to Their Own Pharmacies, Says FTC
(July 9): Drug middlemen paid their own mail-order pharmacies as much as 200 times more than the price at rival pharmacies for commonly prescribed cancer drugs, allowing them to bring in at least US$1 billion (RM4.71 billion) in excess revenue and potentially raising the costs to patients, the US Federal Trade Commission (FTC) found in an interim study.
Here's What to Expect From Labcorp Holdings' Next Earnings Report
Laboratory Corp. Price Target Raised to $215.00/Share From $210.00 by Evercore ISI Group
Laboratory Corp. Price Target Raised to $215.00/Share From $210.00 by Evercore ISI
Laboratory Corp. Is Maintained at In-Line by Evercore ISI Group
Laboratory Corp. Is Maintained at In-Line by Evercore ISI
No Data